 Marvin Caruthers
Concepts (397)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA | 45 | 2020 | 1463 | 4.100 |
Why?
| | Oligonucleotides | 22 | 2022 | 151 | 3.600 |
Why?
| | Organophosphorus Compounds | 12 | 2023 | 85 | 3.340 |
Why?
| | Morpholinos | 7 | 2024 | 29 | 2.680 |
Why?
| | Organophosphonates | 8 | 2020 | 97 | 2.400 |
Why?
| | Oligodeoxyribonucleotides | 35 | 2017 | 141 | 2.340 |
Why?
| | Oligonucleotides, Antisense | 10 | 2025 | 116 | 1.740 |
Why?
| | Boranes | 6 | 2020 | 7 | 1.520 |
Why?
| | Phosphates | 5 | 2020 | 180 | 1.230 |
Why?
| | Phosphonoacetic Acid | 6 | 2020 | 10 | 1.080 |
Why?
| | RNA | 12 | 2023 | 940 | 1.070 |
Why?
| | Boron Compounds | 3 | 2015 | 29 | 0.990 |
Why?
| | Silver | 3 | 2015 | 38 | 0.860 |
Why?
| | Amides | 5 | 2017 | 101 | 0.790 |
Why?
| | Phosphoric Acids | 4 | 2017 | 17 | 0.710 |
Why?
| | HeLa Cells | 11 | 2021 | 650 | 0.690 |
Why?
| | Phosphorus | 1 | 2020 | 99 | 0.620 |
Why?
| | Lac Operon | 14 | 1986 | 44 | 0.560 |
Why?
| | Thionucleotides | 9 | 2003 | 35 | 0.550 |
Why?
| | Cations | 2 | 2015 | 82 | 0.540 |
Why?
| | Pyridinium Compounds | 1 | 2017 | 31 | 0.500 |
Why?
| | DNA, Neoplasm | 1 | 2017 | 163 | 0.490 |
Why?
| | Base Sequence | 57 | 2011 | 2190 | 0.470 |
Why?
| | Cyclohexenes | 1 | 2015 | 5 | 0.470 |
Why?
| | MicroRNAs | 2 | 2020 | 701 | 0.470 |
Why?
| | Oligoribonucleotides | 6 | 2011 | 52 | 0.470 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2008 | 179 | 0.460 |
Why?
| | Platinum | 2 | 2013 | 50 | 0.460 |
Why?
| | Exonucleases | 1 | 2015 | 8 | 0.460 |
Why?
| | Molecular Structure | 5 | 2020 | 499 | 0.420 |
Why?
| | Chemistry | 7 | 2011 | 41 | 0.410 |
Why?
| | Foscarnet | 2 | 2020 | 20 | 0.410 |
Why?
| | Genes | 23 | 1984 | 226 | 0.400 |
Why?
| | Thymidine | 3 | 2012 | 60 | 0.380 |
Why?
| | Indicators and Reagents | 12 | 2013 | 106 | 0.370 |
Why?
| | Alternative Splicing | 2 | 2025 | 247 | 0.360 |
Why?
| | RNA Splicing | 7 | 2022 | 284 | 0.360 |
Why?
| | Nanostructures | 1 | 2013 | 117 | 0.360 |
Why?
| | Gold | 1 | 2012 | 115 | 0.350 |
Why?
| | Nucleosides | 2 | 2011 | 25 | 0.350 |
Why?
| | Sulfur Compounds | 1 | 2011 | 8 | 0.350 |
Why?
| | Genetic Techniques | 1 | 2011 | 67 | 0.330 |
Why?
| | Biology | 1 | 2011 | 91 | 0.330 |
Why?
| | Morpholines | 1 | 2011 | 128 | 0.330 |
Why?
| | Organothiophosphates | 3 | 2003 | 5 | 0.310 |
Why?
| | Repressor Proteins | 12 | 1990 | 437 | 0.310 |
Why?
| | Oxidation-Reduction | 5 | 2015 | 1087 | 0.300 |
Why?
| | Sulfhydryl Compounds | 4 | 2011 | 189 | 0.300 |
Why?
| | Solid-Phase Synthesis Techniques | 3 | 2015 | 10 | 0.300 |
Why?
| | Magnetic Resonance Spectroscopy | 9 | 2015 | 630 | 0.290 |
Why?
| | Reverse Transcriptase Inhibitors | 4 | 1993 | 87 | 0.290 |
Why?
| | Nucleic Acid Hybridization | 6 | 2015 | 187 | 0.280 |
Why?
| | Acids | 1 | 2008 | 17 | 0.270 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 758 | 0.270 |
Why?
| | Escherichia coli | 27 | 1987 | 854 | 0.270 |
Why?
| | Chemistry Techniques, Synthetic | 2 | 2019 | 15 | 0.260 |
Why?
| | Nucleic Acid Conformation | 13 | 2017 | 726 | 0.260 |
Why?
| | Antiviral Agents | 4 | 1995 | 767 | 0.250 |
Why?
| | Phosphines | 2 | 2020 | 18 | 0.250 |
Why?
| | Chromatography, High Pressure Liquid | 10 | 2006 | 594 | 0.240 |
Why?
| | Pyruvate Kinase | 1 | 2025 | 28 | 0.220 |
Why?
| | Thyroid Hormones | 1 | 2025 | 67 | 0.220 |
Why?
| | Molecular Biology | 2 | 2005 | 59 | 0.220 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2025 | 138 | 0.210 |
Why?
| | Microscopy, Electron, Transmission | 3 | 2015 | 157 | 0.210 |
Why?
| | RNA-Binding Protein FUS | 1 | 2024 | 15 | 0.210 |
Why?
| | DNA, Bacterial | 16 | 1986 | 342 | 0.210 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2025 | 175 | 0.210 |
Why?
| | Peroxides | 1 | 2003 | 19 | 0.200 |
Why?
| | Cell Nucleus | 3 | 2021 | 618 | 0.200 |
Why?
| | History, 20th Century | 3 | 2014 | 325 | 0.200 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2024 | 99 | 0.200 |
Why?
| | Nonsense Mediated mRNA Decay | 1 | 2023 | 19 | 0.190 |
Why?
| | MAP Kinase Signaling System | 1 | 2025 | 310 | 0.190 |
Why?
| | Muscular Dystrophy, Facioscapulohumeral | 1 | 2023 | 29 | 0.190 |
Why?
| | Biochemistry | 2 | 2001 | 36 | 0.190 |
Why?
| | History, 21st Century | 2 | 2014 | 219 | 0.180 |
Why?
| | Phosphopeptides | 1 | 2002 | 20 | 0.180 |
Why?
| | Organoids | 1 | 2024 | 141 | 0.180 |
Why?
| | Esters | 5 | 2015 | 78 | 0.180 |
Why?
| | Jurkat Cells | 2 | 2015 | 114 | 0.180 |
Why?
| | Nucleic Acid Denaturation | 3 | 2017 | 32 | 0.170 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2022 | 91 | 0.170 |
Why?
| | Structure-Activity Relationship | 11 | 2011 | 570 | 0.170 |
Why?
| | Alleles | 1 | 2024 | 879 | 0.170 |
Why?
| | Bacteriophage lambda | 4 | 1987 | 90 | 0.170 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2025 | 370 | 0.170 |
Why?
| | DNA, Viral | 7 | 1984 | 358 | 0.170 |
Why?
| | Transcription Factors | 9 | 1997 | 1741 | 0.160 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2005 | 143 | 0.160 |
Why?
| | Thymine | 3 | 1995 | 17 | 0.160 |
Why?
| | Genetic Therapy | 1 | 2022 | 313 | 0.160 |
Why?
| | Polydeoxyribonucleotides | 9 | 1983 | 14 | 0.160 |
Why?
| | Operon | 7 | 1985 | 69 | 0.150 |
Why?
| | Acetic Acid | 1 | 2019 | 21 | 0.150 |
Why?
| | Cell Line | 4 | 2021 | 2882 | 0.150 |
Why?
| | RNA, Messenger | 6 | 2022 | 2832 | 0.150 |
Why?
| | Kinetics | 19 | 2001 | 1627 | 0.150 |
Why?
| | RNA, Long Noncoding | 1 | 2021 | 177 | 0.140 |
Why?
| | Telomerase | 1 | 2021 | 248 | 0.140 |
Why?
| | Operator Regions, Genetic | 2 | 1990 | 8 | 0.140 |
Why?
| | HIV-1 | 3 | 1995 | 896 | 0.140 |
Why?
| | Molecular Mimicry | 2 | 2012 | 37 | 0.140 |
Why?
| | Membrane Proteins | 1 | 2025 | 1166 | 0.140 |
Why?
| | Liver Neoplasms | 1 | 2025 | 780 | 0.140 |
Why?
| | Stereoisomerism | 2 | 2015 | 104 | 0.140 |
Why?
| | RNA, Transfer | 17 | 1976 | 144 | 0.140 |
Why?
| | Molecular Sequence Data | 11 | 1996 | 2930 | 0.140 |
Why?
| | Pancreatic Neoplasms | 2 | 2024 | 919 | 0.130 |
Why?
| | Transition Temperature | 1 | 2017 | 29 | 0.130 |
Why?
| | Humans | 25 | 2025 | 144759 | 0.130 |
Why?
| | Temperature | 4 | 2015 | 679 | 0.130 |
Why?
| | Small Molecule Libraries | 1 | 2017 | 111 | 0.120 |
Why?
| | RNA Precursors | 2 | 2021 | 156 | 0.120 |
Why?
| | Nucleotides | 4 | 2015 | 128 | 0.120 |
Why?
| | Antigens, Viral, Tumor | 2 | 1985 | 7 | 0.110 |
Why?
| | Simian virus 40 | 2 | 1985 | 24 | 0.110 |
Why?
| | Ethylamines | 1 | 2015 | 5 | 0.110 |
Why?
| | Genes, Viral | 4 | 1985 | 90 | 0.110 |
Why?
| | Mutation | 15 | 1990 | 4089 | 0.110 |
Why?
| | Organothiophosphorus Compounds | 1 | 2014 | 1 | 0.110 |
Why?
| | Molecular Dynamics Simulation | 1 | 2017 | 259 | 0.110 |
Why?
| | Huntingtin Protein | 1 | 2014 | 13 | 0.110 |
Why?
| | Iodine | 1 | 2015 | 26 | 0.110 |
Why?
| | Azides | 1 | 2015 | 47 | 0.110 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2015 | 192 | 0.110 |
Why?
| | Dimerization | 1 | 2015 | 194 | 0.110 |
Why?
| | Metal Nanoparticles | 1 | 2015 | 85 | 0.110 |
Why?
| | Solvents | 3 | 2012 | 113 | 0.100 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 2005 | 331 | 0.100 |
Why?
| | RNA, Catalytic | 3 | 2001 | 189 | 0.100 |
Why?
| | Deoxyribonucleotides | 2 | 1992 | 20 | 0.100 |
Why?
| | Cattle | 2 | 2015 | 1000 | 0.100 |
Why?
| | Plasmids | 7 | 1985 | 379 | 0.100 |
Why?
| | Microarray Analysis | 1 | 2013 | 117 | 0.100 |
Why?
| | Alcohols | 1 | 2012 | 28 | 0.090 |
Why?
| | HIV | 2 | 1991 | 250 | 0.090 |
Why?
| | Microscopy, Atomic Force | 1 | 2013 | 134 | 0.090 |
Why?
| | DNA-Directed RNA Polymerases | 4 | 1987 | 63 | 0.090 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 2 | 2006 | 346 | 0.090 |
Why?
| | Nobel Prize | 1 | 2011 | 6 | 0.090 |
Why?
| | Molecular Weight | 2 | 2008 | 327 | 0.090 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2011 | 17 | 0.090 |
Why?
| | Promoter Regions, Genetic | 3 | 1987 | 1257 | 0.090 |
Why?
| | Models, Biological | 3 | 2011 | 1821 | 0.090 |
Why?
| | Cell Membrane Permeability | 1 | 2011 | 85 | 0.080 |
Why?
| | Organophosphates | 1 | 2012 | 187 | 0.080 |
Why?
| | Deoxycytidine | 1 | 1992 | 221 | 0.080 |
Why?
| | Lactose | 4 | 1977 | 7 | 0.080 |
Why?
| | DNA, Recombinant | 3 | 1984 | 48 | 0.080 |
Why?
| | Transcription, Genetic | 17 | 1991 | 1496 | 0.080 |
Why?
| | Animals | 12 | 2022 | 38058 | 0.080 |
Why?
| | Alanine | 7 | 1972 | 171 | 0.080 |
Why?
| | Polynucleotides | 8 | 1975 | 14 | 0.080 |
Why?
| | Nucleic Acid Heteroduplexes | 2 | 2007 | 9 | 0.080 |
Why?
| | Cloning, Molecular | 6 | 1990 | 540 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 635 | 0.070 |
Why?
| | Water | 1 | 2012 | 469 | 0.070 |
Why?
| | Purines | 1 | 2010 | 187 | 0.070 |
Why?
| | Binding Sites | 10 | 1985 | 1329 | 0.070 |
Why?
| | Genetic Code | 3 | 1977 | 25 | 0.070 |
Why?
| | Reproducibility of Results | 2 | 2008 | 3409 | 0.070 |
Why?
| | Lactose Factors | 2 | 1977 | 2 | 0.070 |
Why?
| | Ribonuclease H | 3 | 2003 | 12 | 0.060 |
Why?
| | Esterification | 1 | 2007 | 9 | 0.060 |
Why?
| | Transfection | 2 | 2007 | 940 | 0.060 |
Why?
| | Receptors, Cyclic AMP | 2 | 1984 | 3 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1054 | 0.060 |
Why?
| | Nanoparticles | 1 | 2012 | 519 | 0.060 |
Why?
| | DNA-Binding Proteins | 3 | 1997 | 1499 | 0.060 |
Why?
| | Saccharomyces cerevisiae | 5 | 1972 | 579 | 0.060 |
Why?
| | Biophysical Phenomena | 1 | 2006 | 68 | 0.060 |
Why?
| | Nuclear Proteins | 1 | 1991 | 748 | 0.060 |
Why?
| | Models, Chemical | 2 | 2005 | 269 | 0.060 |
Why?
| | Flow Cytometry | 3 | 2007 | 1173 | 0.060 |
Why?
| | Oncogene Proteins, Viral | 1 | 1985 | 20 | 0.060 |
Why?
| | Biophysics | 1 | 2006 | 74 | 0.060 |
Why?
| | Deoxyribonuclease I | 3 | 2003 | 41 | 0.060 |
Why?
| | Polynucleotide Ligases | 7 | 1977 | 8 | 0.060 |
Why?
| | Thermodynamics | 7 | 2001 | 426 | 0.060 |
Why?
| | United States | 2 | 2014 | 15966 | 0.060 |
Why?
| | Amino Acid Sequence | 5 | 2002 | 2155 | 0.060 |
Why?
| | Mass Spectrometry | 3 | 2005 | 750 | 0.060 |
Why?
| | Lithium Chloride | 1 | 2005 | 12 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2025 | 3540 | 0.060 |
Why?
| | Acetonitriles | 1 | 2005 | 13 | 0.060 |
Why?
| | Genetic Engineering | 1 | 1985 | 93 | 0.060 |
Why?
| | Chromatography, Ion Exchange | 2 | 2003 | 57 | 0.050 |
Why?
| | In Vitro Techniques | 2 | 2022 | 1047 | 0.050 |
Why?
| | Macromolecular Substances | 1 | 2005 | 224 | 0.050 |
Why?
| | Automation | 1 | 2004 | 102 | 0.050 |
Why?
| | Genes, Bacterial | 1 | 1984 | 166 | 0.050 |
Why?
| | Polymers | 3 | 2005 | 499 | 0.050 |
Why?
| | Anions | 1 | 2003 | 31 | 0.050 |
Why?
| | Chemical Phenomena | 6 | 1986 | 81 | 0.050 |
Why?
| | Gene Expression Regulation | 5 | 2023 | 2608 | 0.050 |
Why?
| | Phosphorylation | 2 | 2025 | 1732 | 0.050 |
Why?
| | Protein Kinases | 1 | 1985 | 315 | 0.050 |
Why?
| | Introns | 3 | 2021 | 254 | 0.050 |
Why?
| | Gene Knockdown Techniques | 1 | 2024 | 336 | 0.050 |
Why?
| | Cell Compartmentation | 2 | 2021 | 54 | 0.050 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2023 | 26 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1985 | 0.050 |
Why?
| | Mice, Inbred mdx | 1 | 2022 | 12 | 0.050 |
Why?
| | HIV Reverse Transcriptase | 2 | 1993 | 31 | 0.050 |
Why?
| | Yersinia enterocolitica | 1 | 2002 | 7 | 0.050 |
Why?
| | Polyethylene Glycols | 2 | 2005 | 654 | 0.050 |
Why?
| | Coliphages | 8 | 1984 | 9 | 0.050 |
Why?
| | Enzyme Activation | 2 | 1996 | 766 | 0.050 |
Why?
| | DNA, Circular | 1 | 1982 | 15 | 0.050 |
Why?
| | DNA Restriction Enzymes | 5 | 1985 | 53 | 0.040 |
Why?
| | Up-Regulation | 1 | 2025 | 851 | 0.040 |
Why?
| | Lipids | 1 | 2007 | 710 | 0.040 |
Why?
| | DNA Adducts | 1 | 2001 | 16 | 0.040 |
Why?
| | Human Embryonic Stem Cells | 1 | 2021 | 26 | 0.040 |
Why?
| | HCT116 Cells | 1 | 2021 | 78 | 0.040 |
Why?
| | Single-Strand Specific DNA and RNA Endonucleases | 2 | 1996 | 10 | 0.040 |
Why?
| | Tetrahymena thermophila | 1 | 2001 | 68 | 0.040 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2002 | 167 | 0.040 |
Why?
| | Species Specificity | 2 | 2021 | 574 | 0.040 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2024 | 291 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2021 | 322 | 0.040 |
Why?
| | RNA Stability | 1 | 2021 | 119 | 0.040 |
Why?
| | Mitosis | 1 | 2021 | 200 | 0.040 |
Why?
| | Hypoxanthines | 1 | 1979 | 1 | 0.040 |
Why?
| | Mice | 5 | 2022 | 18339 | 0.040 |
Why?
| | DNA Polymerase I | 1 | 1979 | 31 | 0.040 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 1979 | 48 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2023 | 523 | 0.040 |
Why?
| | Adenoviruses, Human | 3 | 1984 | 26 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2023 | 462 | 0.040 |
Why?
| | Fibroblasts | 1 | 2024 | 1034 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2025 | 1455 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 744 | 0.040 |
Why?
| | Base Composition | 4 | 1987 | 82 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 276 | 0.030 |
Why?
| | Methods | 3 | 1983 | 69 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4154 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2025 | 2496 | 0.030 |
Why?
| | Genes, Regulator | 1 | 1977 | 35 | 0.030 |
Why?
| | Genes, Synthetic | 2 | 1987 | 14 | 0.030 |
Why?
| | DNA, Antisense | 1 | 1995 | 2 | 0.030 |
Why?
| | Genes, erbB-2 | 1 | 1995 | 33 | 0.030 |
Why?
| | Tyrosine | 11 | 1982 | 222 | 0.030 |
Why?
| | Viral Proteins | 3 | 1985 | 355 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 1996 | 230 | 0.030 |
Why?
| | Herpesvirus 1, Human | 1 | 1995 | 84 | 0.030 |
Why?
| | Hot Temperature | 2 | 1991 | 407 | 0.030 |
Why?
| | Protein Binding | 5 | 1997 | 2273 | 0.030 |
Why?
| | Huntington Disease | 1 | 2014 | 61 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 1995 | 370 | 0.030 |
Why?
| | Time Factors | 2 | 2004 | 7173 | 0.030 |
Why?
| | Chemistry, Organic | 2 | 1993 | 6 | 0.030 |
Why?
| | Peptides | 1 | 1979 | 995 | 0.020 |
Why?
| | Catalysis | 3 | 2001 | 322 | 0.020 |
Why?
| | Mercaptoethanol | 1 | 1993 | 9 | 0.020 |
Why?
| | Tumor Cells, Cultured | 3 | 2003 | 919 | 0.020 |
Why?
| | Guanine | 2 | 1986 | 87 | 0.020 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 1992 | 16 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 1995 | 573 | 0.020 |
Why?
| | Cell Fusion | 1 | 1992 | 49 | 0.020 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 1992 | 16 | 0.020 |
Why?
| | Virus Replication | 3 | 1992 | 529 | 0.020 |
Why?
| | Tetrahymena | 1 | 1993 | 158 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2022 | 4557 | 0.020 |
Why?
| | Substrate Specificity | 2 | 2001 | 388 | 0.020 |
Why?
| | Antibodies | 2 | 1990 | 401 | 0.020 |
Why?
| | DNA Ligases | 2 | 1979 | 7 | 0.020 |
Why?
| | Half-Life | 2 | 1978 | 151 | 0.020 |
Why?
| | Protein Biosynthesis | 8 | 1976 | 458 | 0.020 |
Why?
| | Spectrum Analysis | 2 | 1986 | 93 | 0.020 |
Why?
| | Magnesium | 2 | 2000 | 155 | 0.020 |
Why?
| | Uracil | 1 | 1986 | 36 | 0.020 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 1985 | 15 | 0.010 |
Why?
| | Chromosome Mapping | 2 | 1979 | 510 | 0.010 |
Why?
| | Methylation | 1 | 1986 | 242 | 0.010 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 1985 | 27 | 0.010 |
Why?
| | Silicon Dioxide | 2 | 1986 | 121 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2003 | 561 | 0.010 |
Why?
| | Spectrophotometry | 2 | 1983 | 61 | 0.010 |
Why?
| | Electron Transport Complex IV | 1 | 1984 | 62 | 0.010 |
Why?
| | Adenosine Triphosphate | 4 | 1976 | 498 | 0.010 |
Why?
| | Isomerism | 1 | 1984 | 57 | 0.010 |
Why?
| | Protein Precursors | 1 | 1984 | 137 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 1996 | 2452 | 0.010 |
Why?
| | Poly A | 1 | 1983 | 50 | 0.010 |
Why?
| | Isopropyl Thiogalactoside | 1 | 1982 | 1 | 0.010 |
Why?
| | Chromatography, DEAE-Cellulose | 2 | 1972 | 12 | 0.010 |
Why?
| | Circular Dichroism | 1 | 2003 | 150 | 0.010 |
Why?
| | Thioglycosides | 1 | 1982 | 2 | 0.010 |
Why?
| | Color | 1 | 1983 | 81 | 0.010 |
Why?
| | Adenoviridae | 1 | 1983 | 199 | 0.010 |
Why?
| | RNA, Viral | 2 | 1983 | 688 | 0.010 |
Why?
| | Deoxyribonuclease EcoRI | 1 | 1982 | 4 | 0.010 |
Why?
| | Silica Gel | 1 | 1982 | 1 | 0.010 |
Why?
| | Models, Genetic | 1 | 1985 | 536 | 0.010 |
Why?
| | Chromatography | 1 | 1982 | 27 | 0.010 |
Why?
| | Chemical Precipitation | 1 | 1982 | 39 | 0.010 |
Why?
| | Endonucleases | 1 | 1982 | 34 | 0.010 |
Why?
| | Protein Conformation | 1 | 1985 | 946 | 0.010 |
Why?
| | Molecular Probes | 1 | 2001 | 33 | 0.010 |
Why?
| | Static Electricity | 1 | 2000 | 113 | 0.010 |
Why?
| | Cadmium | 1 | 2000 | 69 | 0.010 |
Why?
| | T-Phages | 1 | 1979 | 18 | 0.010 |
Why?
| | Peptide Biosynthesis | 1 | 1979 | 13 | 0.010 |
Why?
| | Sulfur | 1 | 2000 | 64 | 0.010 |
Why?
| | Poly dA-dT | 1 | 1979 | 2 | 0.010 |
Why?
| | Phenotype | 2 | 1985 | 3162 | 0.010 |
Why?
| | Cytosine | 1 | 1979 | 51 | 0.010 |
Why?
| | Polynucleotide 5'-Hydroxyl-Kinase | 2 | 1976 | 2 | 0.010 |
Why?
| | Metals | 1 | 2000 | 142 | 0.010 |
Why?
| | Phosphoric Monoester Hydrolases | 2 | 1976 | 56 | 0.010 |
Why?
| | Bromouracil | 1 | 1978 | 1 | 0.010 |
Why?
| | Transformation, Bacterial | 1 | 1978 | 9 | 0.010 |
Why?
| | Proteins | 1 | 1984 | 1021 | 0.010 |
Why?
| | Transformation, Genetic | 1 | 1977 | 15 | 0.010 |
Why?
| | Chromatography, Gel | 3 | 1972 | 131 | 0.010 |
Why?
| | Lysogeny | 1 | 1977 | 6 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1977 | 167 | 0.010 |
Why?
| | Genes, ras | 1 | 1997 | 96 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1997 | 193 | 0.010 |
Why?
| | DNA Replication | 4 | 1984 | 251 | 0.010 |
Why?
| | HIV Infections | 1 | 1992 | 3154 | 0.010 |
Why?
| | Adenine | 1 | 1979 | 339 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 1997 | 251 | 0.010 |
Why?
| | Blood Chemical Analysis | 1 | 1997 | 109 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1997 | 327 | 0.010 |
Why?
| | Suppression, Genetic | 2 | 1973 | 26 | 0.010 |
Why?
| | Area Under Curve | 1 | 1997 | 330 | 0.010 |
Why?
| | Hydrogen Bonding | 2 | 1986 | 169 | 0.010 |
Why?
| | Drug Stability | 2 | 1986 | 164 | 0.010 |
Why?
| | Spectrophotometry, Ultraviolet | 4 | 1976 | 85 | 0.010 |
Why?
| | Muscles | 1 | 1997 | 333 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2000 | 2027 | 0.010 |
Why?
| | Isotope Labeling | 2 | 1972 | 82 | 0.010 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 1995 | 36 | 0.010 |
Why?
| | Chromatography, Paper | 2 | 1972 | 3 | 0.010 |
Why?
| | G1 Phase | 1 | 1995 | 66 | 0.010 |
Why?
| | Mice, Nude | 1 | 1997 | 682 | 0.010 |
Why?
| | Spleen | 1 | 1997 | 508 | 0.010 |
Why?
| | Oxygen | 1 | 2000 | 995 | 0.010 |
Why?
| | Calorimetry | 2 | 1986 | 72 | 0.010 |
Why?
| | Cell Separation | 1 | 1995 | 307 | 0.010 |
Why?
| | 3T3 Cells | 1 | 1994 | 156 | 0.010 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 1994 | 65 | 0.010 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 1994 | 93 | 0.010 |
Why?
| | Lipopolysaccharide Receptors | 1 | 1994 | 87 | 0.010 |
Why?
| | Iodine Radioisotopes | 1 | 1994 | 136 | 0.010 |
Why?
| | Solubility | 1 | 1994 | 242 | 0.010 |
Why?
| | Peptide Chain Termination, Translational | 1 | 1973 | 9 | 0.010 |
Why?
| | Down-Regulation | 1 | 1995 | 627 | 0.010 |
Why?
| | Isoenzymes | 1 | 1994 | 299 | 0.010 |
Why?
| | Ribonucleotides | 1 | 1973 | 26 | 0.010 |
Why?
| | Manganese | 1 | 1993 | 55 | 0.010 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 1973 | 45 | 0.010 |
Why?
| | Biological Transport | 1 | 1994 | 417 | 0.010 |
Why?
| | Protein Kinase C | 1 | 1994 | 252 | 0.010 |
Why?
| | RNA, Bacterial | 1 | 1973 | 189 | 0.010 |
Why?
| | Antigens, CD | 1 | 1994 | 555 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1994 | 1370 | 0.010 |
Why?
| | Computers | 2 | 1984 | 67 | 0.000 |
Why?
| | Radioimmunoassay | 1 | 1990 | 165 | 0.000 |
Why?
| | Antibody Affinity | 1 | 1990 | 60 | 0.000 |
Why?
| | Antibody Specificity | 1 | 1990 | 181 | 0.000 |
Why?
| | Zinc | 1 | 1993 | 295 | 0.000 |
Why?
| | Kidney | 1 | 1997 | 1495 | 0.000 |
Why?
| | Rabbits | 1 | 1990 | 648 | 0.000 |
Why?
| | Antibody Formation | 1 | 1990 | 294 | 0.000 |
Why?
| | Propionates | 1 | 1967 | 39 | 0.000 |
Why?
| | DNA Nucleotidyltransferases | 3 | 1972 | 11 | 0.000 |
Why?
| | Phosphorus Radioisotopes | 1 | 1986 | 26 | 0.000 |
Why?
| | RNA, Double-Stranded | 1 | 1986 | 56 | 0.000 |
Why?
| | Ligases | 3 | 1972 | 37 | 0.000 |
Why?
| | Solutions | 1 | 1986 | 166 | 0.000 |
Why?
| | Autoanalysis | 1 | 1984 | 8 | 0.000 |
Why?
| | Phenylthiohydantoin | 1 | 1984 | 44 | 0.000 |
Why?
| | Templates, Genetic | 1 | 1983 | 63 | 0.000 |
Why?
| | Cytoplasm | 1 | 1984 | 269 | 0.000 |
Why?
| | Buffers | 1 | 1982 | 55 | 0.000 |
Why?
| | Phosphorus Isotopes | 2 | 1972 | 8 | 0.000 |
Why?
| | Phosphotransferases | 2 | 1972 | 27 | 0.000 |
Why?
| | Alkaline Phosphatase | 2 | 1972 | 145 | 0.000 |
Why?
| | Peptide Fragments | 1 | 1982 | 699 | 0.000 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 1976 | 53 | 0.000 |
Why?
| | Liver | 1 | 1984 | 1887 | 0.000 |
Why?
| | Evaluation Studies as Topic | 1 | 1975 | 166 | 0.000 |
Why?
| | Adenosine Diphosphate | 1 | 1972 | 84 | 0.000 |
Why?
| | Genetics, Microbial | 1 | 1970 | 11 | 0.000 |
Why?
| | Yeasts | 1 | 1970 | 52 | 0.000 |
Why?
| | Female | 1 | 1996 | 78271 | 0.000 |
Why?
| | RNA Nucleotidyltransferases | 1 | 1968 | 23 | 0.000 |
Why?
| | Benzoates | 1 | 1967 | 50 | 0.000 |
Why?
| | Organic Chemistry Phenomena | 1 | 1967 | 2 | 0.000 |
Why?
| | Alkalies | 1 | 1967 | 5 | 0.000 |
Why?
| | Enzymes | 1 | 1968 | 65 | 0.000 |
Why?
| | Electrophoresis | 1 | 1967 | 31 | 0.000 |
Why?
| | Ultraviolet Rays | 1 | 1967 | 388 | 0.000 |
Why?
|
|
Caruthers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|